Zhejiang Nhu Co Ltd (002001) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Zhejiang NHU Company Ltd., together with its subsidiaries, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through Pharmaceutical and Chemical; and Other segments.
Total Revenue Chart for Zhejiang Nhu Co Ltd
Zhejiang Nhu Co Ltd (002001) revenue for FY2025 was CNY 22.3B, a 3.0% change from FY2024. Zhejiang Nhu Co Ltd's revenue grew from CNY 539.1M in 2001 to CNY 22.3B in 2025 (4027.5% over 24 years). Earnings per share grew from CNY 0.02 in 2001 to CNY 1.18 in 2022 (5471.2%). Revenue compound annual growth rate: 5-year CAGR of 16.6%, 10-year CAGR of 19.3%, 20-year CAGR of 15.5%.
Total Revenue (CNY)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- ¥82.55B
- Implied Share Price
- ¥26.86
- Enterprise Value
- ¥78.96B
- Revenue (TTM)
- ¥24.28B
- EBITDA
- ¥10.51B
- Profit Margin
- 29.54%
- Trailing P/E
- 11.48
- Forward P/E
- 11.32
- Price/Book (MRQ)
- 2.35
- Price/Sales (TTM)
- 3.40
- EV/EBITDA
- 7.30
- EV/Revenue
- 3.25
- Dividend Yield
- 3.74%
- Book Value
- ¥11.37
- Free Cash Flow (FY2025)
- ¥6.90B
- Free Cash Flow Yield
- 8.35%
Snapshot as of 5th September 2026 — not point-in-time controlled, may lag the live market by a few days.